Search

everythinglearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Blocking certain brain processes reduces mating behavior in female rats.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

UBM helps hair regrowth in men and women with hair loss.

Statins do not impact BPH and LUTS progression when combined with finasteride.

Finasteride may help prevent chronic bacterial prostatitis, with better results when combined with antibiotics.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Finasteride treatment changes hormone levels in male pattern baldness patients.

Trazodone might help reverse post finasteride syndrome.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Clinicians need to better understand and treat Post-finasteride syndrome.

Tamsulosin increases the risk of floppy iris during eye surgery.

Pre-surgical embolization and a two-stage resection improve outcomes for rare sacral tumors.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Pulmonary artery thrombectomy is safe and effective but not widely used.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.